Long-term follow up and mortality rate of patients of the randomized Freeway Stent Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025135

Enrollment

204

Registered

2021-07-08

Start date

2021-08-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PERIPHERAL ARTERIAL DISEASE (PAD) I70.2

Interventions

Group 1: primary stenting followed by drug eluting balloon post dilatation Group 2: primary stenting followed by standard PTA post dilatation

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients that were included in the Freeway Stent Study.

Exclusion criteria

Exclusion criteria: Inclusion only of Patients that participated in the Freeway Stent Study.

Design outcomes

Primary

Measure	Time frame
Overall mortality rate at 5 years after inclusion in the Freeway Stent Study.	—

Secondary

Measure	Time frame
Mortality rate 2-4 years Revascularization rate 2-5 years SAE 2-5 years	—

Countries

Austria, Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026